Armistice Capital »

Caesars Entertainment shares owned by Armistice Capital

Quarter-by-quarter ownership of Caesars Entertainment (CZR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Caesars Entertainment

Tip: Access up to 7 years of quarterly data

All positions including Caesars Entertainment held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caesars Entertainment by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $723k 16k 46.35

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Caesars Entertainment

Vanguard Group
Henderson Group
HG Vora Capital Management
Edgepoint Investment
Citadel Advisors
Appaloosa
Norges Bank Investment Management
Charles Schwab Investment Management
Goldman Sachs Group
Dimensional Fund Advisors
AQR Capital Management
Principal Financial Group
Lord, Abbett & Co
Bank of New York Mellon
Park West Asset Management

View all funds holding Caesars Entertainment